Company / Profit Margin
GeneDx Holdings Corp. Profit Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-4.9%
FY2025
5-year range
-233.9% / -4.9%
FY2021-FY2025
Trend
+71.3%
vs FY2024
Sector context
#105 of 150
Health Care
What the data says
At -4.9%, GeneDx Holdings Corp.'s profit margin ranks #105 of 150 in the Health Care sector. Profit Margin has increased for 3 consecutive years, from -233.9% in FY2022 to -4.9% in FY2025.
Based on SEC 10-K filings.
-4.9% in FY2025 with a 5-year CAGR of +129.7%.
Improved from -86.8% to -4.9% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +229.0pp
- 5-Year Change
- +129.7pp
- 10-Year Change
- -
Sector benchmark
#105 of 150 in Health CareTop 70% of 150This company -4.9% Sector average -263.0%
▼
+98.1% above sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 71.3% year-over-year.
- Currently 258.0pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4.9% | +71.3% |
| FY2024 | -17.1% | +80.3% |
| FY2023 | -86.8% | +62.9% |
| FY2022 | -233.9% | -102.3% |
| FY2021 | -115.6% | +14.1% |
| FY2020 | -134.6% | -788.9% |
| FY2019 | -15.1% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026